Valuation: Genpharmasec Limited

Market Cap 43Cr 45.36L 39.65L 36.44L 33.97L 64.43L 65.41L 4.38Cr 1.7Cr 21Cr 1.7Cr 1.67Cr 73Cr P/E 2024
-545x
P/E 2025 94.5x
Enterprise Value 42Cr 44.37L 38.79L 35.65L 33.23L 63.03L 63.98L 4.28Cr 1.66Cr 21Cr 1.67Cr 1.63Cr 72Cr EV / Sales 2024
3.47x
EV / Sales 2025 2.96x
Free-Float
55.34%
Yield 2024 *
-
Yield 2025 -
1 day-2.63%
1 week+2.78%
Current month+0.91%
1 month-2.63%
3 months+3.74%
6 months-17.16%
Current year-15.27%
1 week 1.08
Extreme 1.08
1.19
1 month 1.03
Extreme 1.03
1.2
Current year 0.75
Extreme 0.75
1.45
1 year 0.75
Extreme 0.75
2.2
3 years 0.75
Extreme 0.75
8.71
5 years 0.75
Extreme 0.75
12.4
10 years 0.75
Extreme 0.75
18
Manager TitleAgeSince
Director of Finance/CFO 38 01/11/2022
Compliance Officer - 27/03/2024
Director TitleAgeSince
Director/Board Member 57 02/01/2019
Director/Board Member 58 02/01/2019
Director/Board Member - 01/11/2022
Change 5-day change 1-year change 3-year change Capi.($)
-2.63%+2.78%-46.12%-68.56% 64.55L
+3.49%+1.36%-29.04%-11.02% 17TCr
+5.04%+2.73%-5.88%-4.53% 11TCr
+2.80%+3.63%+0.09%+55.31% 5.77TCr
+1.33%+1.39%+55.88%+50.01% 5.38TCr
+3.39%+1.39%-10.26%-39.65% 4.36TCr
+3.50%+11.11% - - 3.65TCr
+3.47%+1.58%-14.08%-43.91% 2.75TCr
+0.20%+4.24%+64.56%-3.33% 2.58TCr
+2.78%+1.17%-8.15%-0.43% 2.13TCr
Average +2.34%+4.48%+0.78%-7.34% 5.39TCr
Weighted average by Cap. +3.31%+3.80%-3.55%+1.07%

Financials

2024 2025
Net sales 30Cr 31.93L 27.92L 25.66L 23.91L 45.36L 46.05L 3.08Cr 1.2Cr 15Cr 1.2Cr 1.17Cr 52Cr 34Cr 35.42L 30.96L 28.45L 26.52L 50.3L 51.07L 3.42Cr 1.33Cr 17Cr 1.33Cr 1.3Cr 57Cr
Net income -12.57L -13.2T -11.54T -10.61T -9.89T -18.75T -19.04T -1L -49.5T -6L -49.55T -48.49T -21.29L 1.23Cr 1L 1L 1L 96.83T 2L 2L 12.47L 5L 60.52L 5L 5L 2.09Cr
Net Debt -18Cr -18.79L -16.42L -15.09L -14.07L -26.68L -27.09L -1.81Cr -70.44L -8.79Cr -70.52L -69L -30Cr -94.03L -98.76T -86.33T -79.34T -73.95T -1L -1L -10L -4L -46.22L -4L -4L -1.59Cr
Logo Genpharmasec Limited
Genpharmasec Limited is an India-based company, which is engaged in the distribution of diagnostic pharma equipment and trading of securities. The Company’s segments include Pharmaceuticals, Trading in Securities, and Laboratory Testing. The Trading in Securities segment invests in the secondary securities market. The Company holds rights to the distribution of equipment, such as i-STAT Analyzers and its Cartridges, manufactured by Abbott Point of Care, USA, all over India. The i-STAT Analyzer is a blood analyzer used in Intensive Care Units (ICUs) of hospitals and provides test results in approximately 10 minutes. The Company’s wholly owned subsidiary includes M/s. Clinigenome India Private Limited.
Employees
10
Date Price Change Volume
03/26/03 ₹1.110 -2.63% 1,60,840
02/26/02 ₹1.140 +3.64% 7,09,814
01/26/01 ₹1.100 0.00% 2,00,865
30/26/30 ₹1.100 -0.90% 2,29,743
29/26/29 ₹1.110 +2.78% 3,10,922
  1. Stock Market
  2. Stocks
  3. ADIRASA Stock